• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Morphosys Ag ADR (NQ: MOR )

    18.96 UNCHANGED
    Last Price Updated: 4:00 PM EDT, Aug 2, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Morphosys Ag ADR

    < Previous 1 2
    ...
    4 5 6 7 8 9 10 11 Next >
    MorphoSys Reports Preliminary Q3 2022 Monjuvi U.S. Sales and Updates Financial Guidance for 2022
    Via ACCESSWIRE
    MorphoSys' Monjuvi Shows Long-Term Durable Response In Blood Cancer Settings
    Via Benzinga
    Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday
    Gainers PepGen Inc. (NASDAQ: PEPG) jumped 110.2% to close at $10.93 after the company announced results from its Phase 1 healthy volunteer trial of PGN-EDO51 for Duchenne Muscular Dystrophy. The trial... 
    Via Benzinga
    MorphoSys AG: Invitation to MorphoSys' Second Quarter and First Half Year 2022 Results Conference Call on August 4 , 2022
    Via ACCESSWIRE
    MorphoSys AG Reports Preliminary Q2 2022 Monjuvi U.S. Sales and Updates Financial Guidance for 2022
    Via ACCESSWIRE
    These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win
    Via Benzinga
    Why Prothena Corporation Shares Are Trading Higher By 76%, Here Are 53 Stocks Moving In Wednesday's Mid-Day Session
    Gainers 
    Via Benzinga
    MorphoSys Stock Skyrockets On Entering Equity Participation and License Agreements With HIBio
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    It's time for another dive into the biggest pre-market stock movers as we check out what's going on on Wednesday morning. 
    Via InvestorPlace
    Why MindMed Is Trading Lower By Around 35%; Here Are 31 Stocks Moving Premarket
    Gainers Atlis Motor Vehicles Inc (NASDAQ: AMV) rose 211.7% to $256.00 in pre-market trading after jumping around 199% on Tuesday. 
    Via Benzinga
    Biogen, Eli Lilly And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
    U.S. stock futures traded lower this morning. Here are some big stocks moving higher in today’s pre-market trading session. 
    Via Benzinga
    MorphoSys AG Reports Second Quarter and First Half 2022 Financial Results
    From MorphoSys AG
    Via Business Wire
    Devon Energy Produces A Record Quarter, Dividend Raised By 22%
    Devon Energy produced another record quarter of profits, as higher volumes and prices provided significant tailwinds to results. 
    Via MarketBeat
    MorphoSys AG: Invitation to MorphoSys' Second Quarter and First Half Year 2022 Results Conference Call on August 4 , 2022
    Conference Call Alert 
    From MorphoSys AG
    Via AccessWire
    MorphoSys Reports Preliminary Q2 2022 Monjuvi U.S. Sales and Updates Financial Guidance for 2022
    PLANEGG/MUNICH, GERMANY / ACCESSWIRE / July 26, 2022 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) today reported preliminary U.S. net product sales of Monjuvi® (tafasitamab-cxix) for the second quarter 2022... 
    From MorphoSys AG
    Via AccessWire
    MorphoSys Reports Preliminary Q2 2022 Monjuvi U.S. Sales and Updates Financial Guidance for 2022
    Via ACCESSWIRE
    MorphoSys AG Reports Preliminary Q2 2022 Monjuvi U.S. Sales and Updates Financial Guidance for 2022
    Publication of an inside information according to Article 17 para. 1 of the Regulation (EU) No. 596/2014 
    From MorphoSys AG
    Via AccessWire
    21 Stocks Moving in Wednesday's Pre-Market Session
    Gainers Codex DNA, Inc. (NASDAQ: DNAY) rose 64.5% to $3.52 in pre-market trading after declining 10% on Tuesday. 
    Via Benzinga
    Week In Review: Joincare Plans $300-$400 Million IPO On Swiss Exchange
    Joincare Pharmaceutical of Shenzhen plans to list on the SIX Swiss stock exchange, an unusual venue for a China biopharma. The company said it aims to broaden its financing sources and increase global... 
    Via Talk Markets
    55 Stocks Moving In Wednesday's Mid-Day Session
    Gainers Sidus Space, Inc. (NASDAQ: SIDU) shares surged 92.4% to $2.77 after the company announced it is part of Collins Aerospace team which was awarded NASA's Exploration Extravehicular Activity... 
    Via Benzinga
    The Daily Biotech Pulse: FDA Committee Backs Moderna Shot For 5-17 Years, 180 Life Sciences Stock Plunges, Pfizer's Posts Disappointing Paxlovid Data
    Here's a roundup of top developments in the biotech space over the last 24 hours: 
    Via Benzinga
    24 Stocks Moving in Wednesday's Pre-Market Session
    Gainers Boxed, Inc. (NYSE: BOXD) rose 38.3% to $1.95 in pre-market trading. Boxed reported that Director Andrew Pearson bought 150,000 shares at an average price of $1.82 per share. 
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Gainers 
    Via Benzinga
    MorphoSys and HIBio Enter Into Equity Participation and License Agreements for Felzartamab and MOR210
    From MorphoSys AG
    Via Business Wire
    The Daily Biotech Pulse: FDA Nod For Lilly-Incyte's Patchy Hair Loss Treatment, First Regulatory Submission For EQRx, Soleno's Promising Data From Prader-Willi Candidate
    Here's a roundup of top developments in the biotech space over the last 24 hours: 
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Gainers 
    Via Benzinga
    MorphoSys Presents Multiple Analyses of the MANIFEST Phase 2 Trial Investigating the Potential of Pelabresib in the Treatment of Myelofibrosis at EHA 2022
    From MorphoSys
    Via Business Wire
    MorphoSys AG Reports Outcome of Annual General Meeting 2022
    PLANEGG/MUNICH, GERMANY / ACCESSWIRE / May 18, 2022 / MorphoSys AG (FSE:MOR); (NASDAQ:MOR) announced today that its shareholders approved all resolutions proposed by the Company´s Management and... 
    From MorphoSys AG
    Via AccessWire
    MorphoSys to Present New Data on Pelabresib and Monjuvi® (tafasitamab-cxix) at the 2022 European Hematology Association (EHA) and American Society of Clinical Oncology (ASCO) Annual Meetings
    From MorphoSys
    Via Business Wire
    MorphoSys AG Reports First Quarter 2022 Financial Results
    From MorphoSys AG
    Via Business Wire
    < Previous 1 2
    ...
    4 5 6 7 8 9 10 11 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.